FDA reverses decision to pull Shire drug; India eyes task force on pharma …FiercePharmaReport > Icelandic drugmaker Actavis said on Tuesday it aimed to join the race to develop generic copies of pricey biotech medicines by buying a majority …

Related PostsJuly 30, 2010 — News and FDA Updates for Abraxis (NASDAQ:ABII), ACADIA (Nasdaq:ACAD), ACCESS … [...]

BRAI a huge step forward: RameshIndian ExpressHe said: The Biotechnology Regulatory Authority of India (Bill to be introduced in Parliament within the next few days is a huge step forward for …
and more »

Related PostsMarch 7, 2010 — Corporatising agriculture – Express BuzzFebruary 23, 2010 — FOOD FOR THOUGHT – Calcutta TelegraphJuly 10, 2010 — How [...]

India as a superpower Why and why not?OrganiserAt present India has demonstrated innovative capacity in Chip design, Thorium reactors, Biotech, and Pharmaceuticals. Then what is holding Indians back from …
and more »

Related PostsSeptember 7, 2010 — FDA reverses decision to pull Shire drug; India eyes task force on pharma … – FiercePharmaSeptember 2, 2010 — STADA [...]

Biocon unveils healthcare unit for critical illnessesThaindian.com“There is a perceptible increase in hospital acquired infections with respect to critical care illnesses in India. This often requires treatment with …
and more »

Related PostsSeptember 7, 2010 — FDA reverses decision to pull Shire drug; India eyes task force on pharma … – FiercePharmaAugust 20, 2010 — BRAI a [...]

PhRMA-funded study questions FTC claims; Abbott India poaches Wockhardt sales …FiercePharmaReport @FierceBiotech: GSK orders Sirtris execs to stop selling resveratrol. Article | Follow @FierceBiotech > The virtual model works for biotech, …

Related PostsMay 23, 2010 — Sunil Jain: Rest of the 'piram-id' – Business StandardSeptember 7, 2010 — FDA reverses decision to pull Shire drug; [...]

Clinical Trials in India – new market report and analysis releasedPR-inside.com (press release)India has become a favourite location for global pharmaceutical and biotech companies for clinical trials in new products. The simple reasons are: Due to …
and more »

Related PostsJuly 21, 2010 — Pharmarama International is Named One of Britain's Leading Private Companies … – Business [...]

Calcutta Tube (blog)

World Traveller on Biotruck Andy Pag: India’s problem is carbon unawarenessCalcutta Tube (blog)In Asia, bio-fuel companies like Emami, Royal Energy and Gomti Biotech came forward to sponsor him, Pag said. He said travelling by road, even without the …

Related PostsAugust 7, 2010 — 'India's problem is carbon unawareness' – indiabloomsAugust 21, 2010 — [...]

indiablooms

‘India’s problem is carbon unawareness’indiabloomsIn Asia, bio-fuel companies like Emami, Royal Energy and Gomti Biotech came forward to sponsor him, Pag said. He said travelling by road, even without the …

Related PostsAugust 8, 2010 — World Traveller on Biotruck Andy Pag: India's problem is carbon unawareness – Calcutta Tube (blog)August 21, 2010 — Driving around [...]

GM Crops: Engine of Economic MobilityTruth about Trade & TechnologyLet’s hope that officeholders in India and elsewhere also choose to accept GM eggplants and other biotech crops–and quit chickening out in the face of …

Related PostsMarch 14, 2010 — Australia – The GM Crops debate – Meattradenewsdaily (blog)March 3, 2010 — Planting of GM crops [...]

Siliconindia.com

R&D in India: 79K patents are pending with Indian Govt.Siliconindia.comSix domestic pharmaceutical and biotech companies – Ranbaxy, Dr. Reddy’s Labs, Orchid Pharmaceuticals, Cadila Healthcare, Cipla and Sun Pharmaceuticals …
and more »

Related PostsFebruary 28, 2010 — FM injects new life into pharma – Times of IndiaAugust 8, 2010 — Clinical Trials in India – new market report [...]